Eukaryotic elongation factor-1&alpha; 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-&kappa;B signaling

doi:10.3748/wjg.v22.i16.4226

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11889)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-2) series.

Item

Count

PDF

749

WORD

285

HTML

5435

Figures (1-8)

566

Tables (1-2)

445

Sum=7480

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1531

Download

2878

Sum=4409

Apr 28, 2016 (publication date) through Oct 25, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastroenterol. Apr 28, 2016; 22(16): 4226-4237
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4226

Table 1 Primers used in this study

Gene	Primers (5’-3’)	Length (bp)
eEF1A2	GTCAAGGAAGTCAGCGCCTAC	124
	TGAACCACGGCATGTTGGG
GAPDH	TGACTTCAACAGCGACACCCA	121
	CACCCTGTTGCTGTAGCCAAA

Full Size Table

Table 2 eEF1A2 expression in hepatocellular carcinoma, paired pericarcinomatous and normal liver tissue samples

	eEF1A2 positive tissue/total tissue	Positive rate
HCC	47/62	75.8%
Paired pericarcinomatous	5/62	8.1%
Normal liver	0/20	0%

eEF1A2: Eukaryotic elongation factor 1 alpha 2; HCC: Hepatocellular carcinoma.

Full Size Table

Citation: Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol 2016; 22(16): 4226-4237
URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4226.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i16.4226